Trial intelligence / Profile preview

Taxol in advanced vulvar cancer

NCT00014599Phase 2Completed

Sponsor
European Organisation for Research and Treatment of Cancer
Start
Feb 2001
Primary completion
Feb 2005
Modality
Small Molecules
Countries
6
01

Overview

A Phase 2 trial of paclitaxel in vulvar cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Feb 2001; status: completed.

02

Drugs

paclitaxel
03

Conditions

vulvar cancer

Beyond the preview

Go deeper on NCT00014599.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00014599.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call